首页> 外文期刊>Free Radical Biology and Medicine: The Official Journal of the Oxygen Society >Noninvasive Retinal Optical Imaging in Metabolic Diseases Mouse Models Using Optical Coherence Tomography
【24h】

Noninvasive Retinal Optical Imaging in Metabolic Diseases Mouse Models Using Optical Coherence Tomography

机译:使用光学相干断层扫描的代谢疾病小鼠模型中的非侵入式视网膜光学成像

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives To evaluate retinal thickness, microvasculature, blood flow rate and oxygen metabolic rate in glutaredoxin-1 (Glrx) knock out induced metabolic disease mouse models. Methods Twenty-week old wild type and Glrx knock out mice fed with normal chow diet were imaged. Visible-light optical coherence tomography (vis-OCT) was used to image retinal thickness and microvasulature, as well as functional parameters including retinal blood flow rate and oxygen saturation (sO2). These quantitative measurements were compared between wild type and Glrx knock out mice. Results We observed that the retinal thickness was significantly decreased in Glrx knock out mice compared with wild type mice. Additionally, we found significant reduction in arteriovenous sO2 difference in these mice, indicating lower oxygen extraction efficiency. However, Glrx knockout mice did not exhibit any differences in retinal blood flow rate as well as the density of microvasculature. Conclusions vis-OCT provides an unprecedented capability for high-resolution imaging of mouse retinal vessels, in venous sO2 and blood flow that may play a pivotal role in providing a noninvasive method for detection of early microvascular changes in patients with retinopathy. Glutaredoixn-1 plays a very important role in metabolic disorder induced retinopathy.
机译:谷氨酸毒素-1(GLRX)中的视网膜厚度,微血管结构,血流量和氧代谢率敲除诱导代谢疾病小鼠模型的目的。方法对二十周的野生型和GLRX敲除小鼠喂养正常的味道饮食。可见光光学相干断层扫描(VIS-OCT)用于图像视网膜厚度和微扫描,以及功能参数,包括视网膜血流率和氧饱和度(SO2)。比较野生型和GLRX敲除小鼠之间的这些定量测量。结果我们观察到与野生型小鼠相比,GLRX敲除小鼠的视网膜厚度显着降低。另外,我们发现这些小鼠中的动静脉SO2差异显着降低,表明较低的氧气提取效率。然而,Glrx敲除小鼠没有表现出视网膜血流率的任何差异以及微血管生成的密度。结论VIS-OCT提供了小鼠视网膜血管的高分辨率成像,在静脉SO2和血流中提供了前所未有的能力,该静脉SO2和血流可在提供无血管疗法检测性视网膜病变患者的早期微血管变化方面发挥关键作用。 Glutaredoixn-1在代谢紊乱诱发视网膜病变中起着非常重要的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号